These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20450295)

  • 1. New challenges for a second-generation low-molecular-weight heparin: focus on bemiparin.
    Martínez-González J; Rodríguez C
    Expert Rev Cardiovasc Ther; 2010 May; 8(5):625-34. PubMed ID: 20450295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bemiparin: second-generation, low-molecular-weight heparin for treatment and prophylaxis of venous thromboembolism.
    Martínez-González J; Vila L; Rodríguez C
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):793-802. PubMed ID: 18570617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bemiparin, an effective and safe low molecular weight heparin: a review.
    Ciccone MM; Cortese F; Corbo F; Corrales NE; Al-Momen AK; Silva A; Zito A; Pinto M; Gesualdo M; Scicchitano P
    Vascul Pharmacol; 2014 Jul; 62(1):32-7. PubMed ID: 24657810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
    Laux V; Perzborn E; Heitmeier S; von Degenfeld G; Dittrich-Wengenroth E; Buchmüller A; Gerdes C; Misselwitz F
    Thromb Haemost; 2009 Nov; 102(5):892-9. PubMed ID: 19888525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis.
    Chapman TM; Goa KL
    Drugs; 2003; 63(21):2357-77. PubMed ID: 14524738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
    Santamaría A; Juárez S; Reche A; Gómez-Outes A; Martínez-González J; Fontcuberta J;
    Int J Clin Pract; 2006 May; 60(5):518-25. PubMed ID: 16700847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effectiveness and safety of bemiparin in a large population of orthopedic patients in a normal clinical practice.
    Otero-Fernández R; Gómez-Outes A; Martínez-González J; Rocha E; Fontcuberta J;
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):75-83. PubMed ID: 17895506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of bemiparin sodium--a new second-generation low molecular weight heparin and its applications in venous thromboembolism.
    Planès A
    Expert Opin Pharmacother; 2003 Sep; 4(9):1551-61. PubMed ID: 12943485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bemiparin: pharmacological profile.
    Sánchez-Ferrer CF
    Drugs; 2010 Dec; 70 Suppl 2():19-23. PubMed ID: 21162606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
    Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
    Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of venous thromboembolism in cancer patients.
    Petralia GA; Kakkar AK
    Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin and low molecular weight heparin in thrombosis and beyond.
    Mousa SA
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are all low molecular weight heparins equivalent in the management of venous thromboembolism?
    Fareed J; Jeske W; Fareed D; Clark M; Wahi R; Adiguzel C; Hoppensteadt D
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):385-92. PubMed ID: 18815137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the anti-factor IIa assay and potency assessment of enoxaparin in pharmaceutical formulations.
    Dalmora SL; Junior LB; Vaccari SF; Fronza M; Renato de Oliveira P; Rolim CM
    Farmaco; 2005 Mar; 60(3):225-9. PubMed ID: 15784241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.